Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiajv Chen
Observed names:
Chen Jiajv,
JIAJV CHEN
Institutions:
Affiliated Hospital of Guizhou Medical University,
Renmin University of China
Observed institutions:
University of Science and Technology of China,
Affiliated Hospital of Guizhou Medical University,
Renmin University of China,
Zhejiang University of Finance and Economics
ORCID:
0000-0003-4990-4302
Observed ORCID:
0000-0003-4990-4302
OpenAlex ID:
A5073211620
After He Jiankui's Case: Chinese Legislative Modifications in Human Embryo Gene Editing
2022
·
Yichao Chen
, Shuren Tao
, et al.
·
Human Gene Therapy
·
12
Rethink the patentability of human embryonic stem cell research findings: Relaxation based on benefit weighing
2021
·
Jiajv Chen
, Wei Li
·
Stem Cell Reports
·
10
PDF
Institutional Framework for the Management of Human Genetic Resources in China
2021
·
Wei Li
, Jiajv Chen
·
Human Gene Therapy
·
9
Is cross-border transfer of China’s human genetic data an impossible mission?
2025
·
Jiajv Chen
, Wei Li
·
Human Genetics
·
6
Realistic Dilemma and Solution of Stem Cell Application Supervision in China
2021
·
Xuekai Xie
, Jiajv Chen
, et al.
·
Stem Cells and Development
·
6
From strict moral standards to ethical neutrality: a policy-guided shift in the patentability of human embryonic stem cells in China
2020
·
Xuekai Xie
, Jiajv Chen
, et al.
·
Stem Cell Research & Therapy
·
6
PDF
The Legal Status and Improvement Path of Human Genetic Data in Gene Therapy in China
2024
·
Jiajv Chen
, Wei Li
·
Human Gene Therapy
·
5
Legal and Ethical Challenges in the Construction of China's Biobanks
2021
·
Jiajv Chen
, Jiayu Huang
, et al.
·
Biotechnology Law Report
·
5
Limiting hESC patents in China under a dual‐value perspective
2022
·
Wei Zhang
, Jiajv Chen
, et al.
·
EMBO Reports
·
4
PDF
A Review of the Legislation of Direct-to-Consumer Genetic Testing in China
2023
·
Chen Yichao
, Li Wei
, et al.
·
Human Gene Therapy
·
3
Emerging, challenges and modernization path of gene privacy in China: from personal privacy to group privacy
2025
·
Jiajv Chen
, Wei Li
·
Philosophy Ethics and Humanities in Medicine
·
2
PDF
Patent infringement evaluation and liability of e-commerce platforms in China
2020
·
Jiajv Chen
, Wei Li
·
Journal of Intellectual Property Law & Practice
·
2
Legitimacy of Experimental Use of Patented Research Tools by Chinese Universities
2020
·
Jiansheng Chen
, Jiajv Chen
, et al.
·
Biotechnology Law Report
·
2
Congenital Duodenal Membrane Requiring Differential Diagnosis from Superior Mesenteric Artery Compression Syndrome: A case report
2026
·
Hongbin Qi
, Xiangren Jin
, et al.
·
Research Square
PDF
Divergent Paths, Convergent Goals: Institutional Experiments in Cell and Gene Therapy Regulation and Payment Between China and the United States
2026
·
Jiajv Chen
, Wei Li
·
Clinical Pharmacology & Therapeutics
Preventing Ethical Risks in Cutting-Edge Biotech: China’s Evolving Governance Model
2026
·
JIAJV CHEN
, MUYE GAO
, et al.
·
Biotechnology Law Report
Reigniting the institutional engine for pharmaceutical access: when policy experiments become new global evidence
2026
·
Jiajv Chen
, Wei Li
·
Frontiers in Public Health
PDF
A Feasible Pathway for Open Access to Human Embryonic Stem Cell Patents — With China's Open License for Patent as the Entry Point
2024
·
JIAJV CHEN
·
Biotechnology Law Report
How to promote the accessibility of technology in the era of hESC patents—A comparative analysis of the systems of the US and China
2023
·
Wei Zhang
, Jiajv Chen
, et al.
·
Stem Cell Reports
Patentability Analysis of “Intelligent” Disease Diagnosis Methods in China in the Era of Smart Health Care
2022
·
Shuren Tao
, Yichao Chen
, et al.
·
Biotechnology Law Report
Show more works
View as search
Works count:
20
Citation count:
72
H-index:
6
I10-index:
2
Year
Topic
Type